News

Joshua A. Boyce, MD, chief of the Division of Allergy and Clinical Immunology at Brigham and Women's Hospital, is the senior author of a paper published in Immunity, "Mast Cells Control Lung Type ...
A new study by researchers at Brigham and Women’s Hospital reveals the mechanisms behind severe inflammation in asthma. The findings demonstrate that prostaglandin E2 (PGE2), a naturally ...
A new study has identified the mechanism that makes all cannabinoids, but particularly CBD, effective at reducing inflammation. The discovery could lead to the development of new therapeutic ...
Asthma is not commonly recognized as a dangerous disease, however, about 10 Americans die each day from it. In addition, about 440,000 hospitalizations and 1.3 million emergency room trips result from ...
Even when inflammation is suppressed by current treatments, underlying airway hyperresponsiveness and airway tissue changes (airway remodeling) often remain, especially in severe asthma." ...
Alopecia areata and asthma are strongly linked, particularly through the inflammatory protein IL-33, suggesting a shared biological pathway and potential for targeted treatments like dupilumab.
This ties in to Rosenkranz’s previous work on the effects of psychological interventions, like mindfulness training, on asthma symptoms and other types of inflammatory responses. 4,5 “Now what we want ...
New, more effective anti-inflammatory drugs are needed to treat asthma. Anti-eosinophil approaches include targeting cytokines (anti-IL-4, -13, and -5), their receptors (βc) or chemokine ...
Insight into immune mechanisms of inflammatory disease Date: November 2, 2022 Source: Weill Cornell Medicine Summary: Innate lymphoid cells are a recently discovered family of white blood cells ...
This review explores the dual role of type 2 inflammation in CVDs, emphasizing its detrimental effects (e.g., exacerbating atherosclerosis) and protective mechanisms (e.g., release of ...
According to a new study, patients with allergic asthma have some protection against COVID-19, as type 2 inflammation can reduce the replication of severe acute respiratory syndrome coronavirus 2 ...